Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
A study by the Bloomberg School of Public Health found that severe COVID-19 patients can produce strong antibodies for vaccine testing - especially the older male population.
According to data collected by Pharma Nord, Google saw a rise in searches for vitamin D during lockdown as the nation becomes more health-conscious amid COVID-19.
Data suggests that only 7% of US schools in poorer, ethnic minority populations will open fully this Autumn - policy-makers are struggling between access to education and protection from infection.
The Potsdam Institute for Climate Impact Research analysed real-time data to understand the impact of this unprecedented lockdown on global carbon emissions.
On 12 October, Prime Minister Boris Johnson announced a “three-tier” system to override previous COVID-19 measures across England - what does that mean?
A clearer balance between primary care communications channels is now emerging from the pandemic. While there are new questions on practice phone costs and patient inclusion, the aim should be for an “omnichannel” approach, argues Paul Bensley, managing director of X-on.
Richard J. C. Brown, Head of Metrology and Jan-Theodoor Janssen, Chief Scientist from the National Physical Laboratory, Teddington, explore why the system doesn’t work if everyone is measuring COVID-related deaths differently and how a standardised international definition of COVID-related deaths could bolster public trust.
With scientists predicting a sharp increase in COVID-19 infections, on 22nd September 2020 the UK Government announced a new round of measures to “confront the COVID-19 virus”
Here, Business Development Director at Aire Logic, Rob Hurrell, explains how COVID-19 has helped us all to become agile and deliver better digital health solutions, faster.
